CVRx, (id:8249 CVRX)
14.70 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/22/2024 12:34:36 PM)
Exchange open, closes in 3 hours 25 minutes
-0.47 USD (-0.47%)
3.89 USD (3.89%)
96.52 USD (96.52%)
97.05 USD (97.05%)
-27.59 USD (-27.59%)
-44.00 USD (-44.00%)
About CVRx,
Market Capitalization 384.34M
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
| Headquarters (address) |
9201 West Broadway Avenue Minneapolis 55445 MN United States |
| Phone | 763 416 2840 |
| Website | https://www.cvrx.com |
| Employees | 200 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | CVRX |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 6.40 - 33.14 |
| Market Capitalization | 384.34M |
| P/E trailing | -6.79 |
| P/E forward | -7.38 |
| Price/Sale | 8.13 |
| Price/Book | 5.86 |
| Beta | 1.11 |
| EPS | -2.68 |
| EPS United States (ID:6, base:3395) | 24.30 |